CSBR:NASDAQ
Champions Oncology Inc
4,34 USD
arrow_downward
−1,36%(−0,060) 1 D
20. nov., 16:00:00 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CSBR …
Åpne
4,45 USD
Høy
4,45 USD
Lav
4,34 USD
Markedsverdi
60,41 mill.
Snittvolum
6,97k
Volum
8,94k
52 u høy
8,31 USD
52 u lav
4,34 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Åpne
4,45 USD
Høy
4,45 USD
Lav
4,34 USD
Markedsverdi
60,41 mill.
Snittvolum
6,97k
Volum
8,94k
52 u høy
8,31 USD
52 u lav
4,34 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Nyhetssaker
Fra nettkilder og nyhetspartnere
WSJ
·
for 1 døgn siden
Dow, S&P 500 Poised to Close at a Correction
Yahoo Finance
·
for 5 timer siden
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
Beinsure
·
for 10 timer siden
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Trefis
·
for 20 timer siden
S&P 500 Movers | Winners: GPN, GIS, MKC | Losers: BE, NVDA, LITE
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Om Champions Oncology Inc
Administrerende direktør-
Ansatte217
Grunnlagt2007
HovedkontorHackensack, New Jersey, USA
SektorHealth Care
Bransje-
Nettstedchampionsoncology.com